Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ameur Manceur"'
Autor:
Elizabeth Marrett, Winghan Jacqueline Kwong, Jinlin Song, Ameur Manceur, Selvam Sendhill, Eric Wu
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 549-563 (2024)
Abstract Introduction Current treatment guidelines for patients with epidermal growth factor receptor (EGFR)-mutated metastatic non-small cell lung cancer (mNSCLC) recommend EGFR tyrosine kinase inhibitors (TKIs) as the standard of care for first-lin
Externí odkaz:
https://doaj.org/article/8c45a52aef9a4ff9a1b789ac8b349e72
Autor:
Mazyar Shadman, Bhavini Srivastava, Sima Patel, Chadi Saifan, Monika Salkar, Bruno Emond, Priyanka Gogna, Ameur Manceur, Marie-Helene Lafeuille, Deborah Stephens
Publikováno v:
HemaSphere, Vol 7, p e24922b0 (2023)
Externí odkaz:
https://doaj.org/article/84610cca2a88495694bedd9f4e9c3430
Autor:
Maryia Zhdanava, Zhijie Ding, Ameur Manceur, Ruizhi Zhao, Christopher Holiday, Sumesh Kachroo, Erik Muser, Dominic Pilon
Publikováno v:
Gastroenterology. 164:S47
BACKGROUND Treatment of Crohn’s disease (CD) may require biologics. Dose escalation may be necessary to maintain efficacy, while adverse events or non-response may lead to treatment discontinuation. This analysis aimed to generate real-world eviden
Autor:
Maryia Zhdanava, Zhijie Ding, Ameur Manceur, Sumesh Kachroo, Christopher Holiday, Ruizhi Zhao, Dominic Pilon
Publikováno v:
Inflammatory Bowel Diseases. 29:S36-S36
BACKGROUND In Crohn’s disease (CD), dose escalation on biologic therapy may be required to maintain effectiveness, while adverse events or non-response, among other factors, may lead to lack of persistence. Understanding persistence while on labele
Autor:
Young, James, Gauthier-Loiselle, Marjolaine, Bailey, Robert, Ameur Manceur, Lefebvre, Patrick, Greenberg, Morris, Marie-HÊlèNe Lafeuille, Duh, Mei, Bookhart, Brahim, Wysham, Carol
Additional file 2. Definition of outcomes and risk factors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::681021982f85f5252d4248132fc45f9f